This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Gregory AI
gregory-ms.com
did:plc:xqiepmiqfqvtv6llwew76ixb
New clinical trial
Open-Label, Single-Center, Single-Arm Phase 2 Futility Trial Evaluating the Use of Oral Indapamide for Reducing Pprogression of Disability in People With Primary and Secondary Progressive Multiple Sclerosis (MS)
#ClinicalTrials #MultipleSclerosis #MSchat #Neurology
https://clinicaltrials.gov/study/NCT07765212?utm_source=fediverse&utm_medium=bsky&utm_content=trial_31717
2026-08-15T07:20:00.672Z